SAN DIEGO, CA -- (MARKET WIRE) -- February 27, 2007 -- Four out of every 10 children suffer from severe nasal allergy symptoms that may affect their overall well-being. Now, clinical research suggests that fluticasone furoate nasal spray (FFNS), a once-a-day allergy medicine under Food and Drug Administration review, effectively treats sneezing, runny nose, nasal itching, and nasal congestion in children 2 to 11 years of age with seasonal and year-round nasal allergies. Moreover, the investigational drug had no effect on children’s short-term growth.
